Decision Tool for Arthritis

Recruiting in Palo Alto (17 mi)

Overseen byRichard C. Mather III, MD, MBA

Age: 18+

Sex: Any

Travel: May Be Covered

Time Reimbursement: Varies

Trial Phase: Academic

Waitlist Available

Sponsor: Duke University

No Placebo Group

Trial Summary

What is the purpose of this trial?This study is an observational study to test and validate a questionnaire and statistical model used to determine patient preferences regarding treatment for any one of 11 musculoskeletal conditions: hip arthritis, knee arthritis, hip labral tears and femoroacetabular impingement (FAI), osteochondritis dissecans, Achilles tendon rupture, patellofemoral dislocation, distal radius fracture, and fractures of the hip, ankle, tibia, and proximal humerus. This study aims to understand how multiple treatment variables, including pain, rehabilitation time, cost, and choice of surgical versus non-surgical intervention, impact patients' decision-making processes and ultimate choice of treatment.

Eligibility Criteria

This trial is for individuals aged 18-85 with various musculoskeletal conditions like hip or knee arthritis, fractures, and tendon ruptures. Specific age ranges apply to different conditions. Parents of children aged 8-18 can participate for certain juvenile conditions.

Inclusion Criteria

I am between 18 and 65 years old with a hip labral tear.

My age matches the trial's requirement for my condition.

I am between 50 and 80 years old with hip arthritis.

+10 more

Exclusion Criteria

Inability to read, understand and give effective English consent

Participant Groups

The study tests a decision tool against standard treatment information to see how patients choose treatments based on factors like pain, recovery time, cost, and surgical vs non-surgical options.

2Treatment groups

Experimental Treatment

Active Control

Group I: Decision toolExperimental Treatment1 Intervention

A "decision tool" will be provided to participants who currently or previously have had one of the following 12 musculoskeletal conditions: hip arthritis, knee arthritis, ankle arthritis, hip labral tears and femoroacetabular impingement (FAI), osteochondritis dissecans, Achilles tendon rupture, patellofemoral dislocation, distal radius fracture, and fractures of the hip, ankle, tibia, and proximal humerus.

Group II: Standard treatment informationActive Control1 Intervention

"Standard treatment information" will be provided to participants who currently or previously have had one of the following 12 musculoskeletal conditions: hip arthritis, knee arthritis, ankle arthritis, hip labral tears and femoroacetabular impingement (FAI), osteochondritis dissecans, Achilles tendon rupture, patellofemoral dislocation, distal radius fracture, and fractures of the hip, ankle, tibia, and proximal humerus.